Skip to content
OpenCapital
Get started

The E.W. Scripps Company SSP Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$516.9M-1.4%
Gross profit$206.1M-0.6%
Operating income$24.8M-9.9%
Net income-$1.8M+48.2%
EPS (diluted)-$0.20+9.1%

Balance sheet

See full
Cash & equivalents$95.0M+297%
Total debt$2.7B-1.6%
Total equity$1.2B-5.6%
Total assets$4.9B-3.9%

Cash flow

See full
Operating cash flow$3.5M+206%
CapEx$3.2M-37.6%
Free cash flow$350.0K+104%

Valuation

See full
Market cap$253.57M+14.3%
Enterprise value$2.84B-3.3%
P/S0.1×0.0×

Profitability

See full
Gross margin40.8%-6.2pp
Operating margin8.5%-7.6pp
Net margin-4.6%-10.3pp
FCF margin0.7%-10.2pp

Returns & leverage

See full
Return on equity-7.7%-19.1pp
Debt / equity2.2×+0.1×
Current ratio1.6×+0.2×